DayTwo is the first personalized, microbiome-enabled, glycemic control product. We profile patients’ gut microbiome and accurately predict their postprandial glycemic response to any food or food combination. Paired with parameters such as A1C, age, height, and weight, our patented algorithm helps practitioners create individualized meal plans for patients to balance blood sugar levels, lower weight, and improve mood and energy. Founded at the Weizmann Institute of Science in 2014, science validated at The Mayo Clinic in 2017 and published in JAMA in early 2019.
1331 N California Blvd
Walnut Creek, California 94596